172 results
Page 7 of 9
8-K
EX-99.1
yi0fuw
2 May 19
Other Events
7:10am
8-K
EX-99.1
3ajjx crk9x
2 Apr 19
Other Events
8:10am
8-K/A
EX-99.1
wg8kiomtq3lrk
27 Feb 19
CORRECTING and REPLACING — Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
5:16pm
8-K
EX-99.1
np9fizimqzip
27 Feb 19
Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
7:43am
8-K
EX-99.1
xz21s6kyh epn
7 Jan 19
Other Events
7:40am
8-K
EX-99.1
m93g5h hi2
12 Dec 18
Adaptimmune Announces that Gwen Binder will leave in January 2019
8:39am
8-K
EX-99.1
l87dfaf jvl
6 Nov 18
Adaptimmune Reports Third Quarter 2018 Financial Results and Business Update
7:36am
8-K
EX-99.1
uff2d7xft4r8bo9qb
22 Oct 18
Other Events
8:38am
8-K
EX-99.1
ywngx7eqpwemd
7 Sep 18
Adaptimmune Therapeutics plc Announces Closing of Registered Direct Offering of American Depositary Shares
12:00am
8-K
EX-99.1
cro8y0 wukjijr7
15 Aug 18
Third Dosing Cohort to be initiated in MAGE-A4 SPEAR T-cell Basket Study After Favorable Review of Safety from One Billion Cell Dose Cohort
7:39am
8-K
EX-99.1
tl8j4y8sw4lf1yj3jokm
2 Aug 18
Adaptimmune Reports Second Quarter 2018 Financial Results and Business Update
7:41am
8-K
EX-99.1
dulnxllzes2sf6p742
24 Jul 18
GSK and Adaptimmune Complete Transition of NY-ESO SPEAR T-cell Therapy Program to GSK
7:36am
8-K
EX-99.1
p7n9bqig ps0d7biic
18 Jul 18
Other Events
5:01pm
8-K
EX-99.1
9lvr9xes3k2 wcug
9 May 18
Adaptimmune Reports First Quarter 2018 Financial Results and Business Update
7:39am